{"title":"Immersive Virtual Reality for Reducing Intraoperative Pain: A Pilot Randomized Controlled Trial.","authors":"Teppei Kamada, Hironori Ohdaira, Ryosuke Nishie, Daisuke Yamagishi, Takashi Aida, Junji Takahashi, Eisaku Ito, Shunjin Ryu, Satoshi Narihiro, Reo Takizawa, Taigo Hata, Masashi Yoshida, Ken Eto, Makoto Sumi, Yutaka Suzuki","doi":"10.21873/invivo.13964","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>In this study, we aimed to evaluate the effect of virtual reality (VR) therapy on pain, anxiety, and other outcomes in patients with cancer undergoing central venous (CV) port placement.</p><p><strong>Patients and methods: </strong>We conducted a single-center randomized controlled trial with 10 adults with cancer undergoing CV port placement. Participants were randomized into the VR group (n=5), which received VR therapy with the Therapeia VR system (xCura), or the control group (n=5), which underwent conventional procedures. The primary and secondary outcomes included intraoperative pain, intraoperative and postoperative anxiety, blood loss, operative time, sensation of obstruction, and patient and surgeon satisfaction.</p><p><strong>Results: </strong>No significant differences were found between the VR and control groups regarding operative time, blood loss, preoperative anxiety, obstruction sensation, or surgeon satisfaction. However, compared with the control group, the VR group showed markedly lower intraoperative pain (<i>p</i>=0.03), intraoperative/postoperative anxiety (<i>p</i>=0.04), and higher patient satisfaction (<i>p</i>=0.03).</p><p><strong>Conclusion: </strong>The use of immersive VR therapy during CV port placement significantly reduced intraoperative pain and anxiety and enhanced patient satisfaction. These findings indicated that VR therapy may be an effective nonpharmacological adjunct for improving patient experience during invasive procedures.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 3","pages":"1638-1646"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041976/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.13964","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aim: In this study, we aimed to evaluate the effect of virtual reality (VR) therapy on pain, anxiety, and other outcomes in patients with cancer undergoing central venous (CV) port placement.
Patients and methods: We conducted a single-center randomized controlled trial with 10 adults with cancer undergoing CV port placement. Participants were randomized into the VR group (n=5), which received VR therapy with the Therapeia VR system (xCura), or the control group (n=5), which underwent conventional procedures. The primary and secondary outcomes included intraoperative pain, intraoperative and postoperative anxiety, blood loss, operative time, sensation of obstruction, and patient and surgeon satisfaction.
Results: No significant differences were found between the VR and control groups regarding operative time, blood loss, preoperative anxiety, obstruction sensation, or surgeon satisfaction. However, compared with the control group, the VR group showed markedly lower intraoperative pain (p=0.03), intraoperative/postoperative anxiety (p=0.04), and higher patient satisfaction (p=0.03).
Conclusion: The use of immersive VR therapy during CV port placement significantly reduced intraoperative pain and anxiety and enhanced patient satisfaction. These findings indicated that VR therapy may be an effective nonpharmacological adjunct for improving patient experience during invasive procedures.
期刊介绍:
IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.